Human Pluripotent Stem Cells on Artificial Microenvironments: a High Content Perspective
Overview
Authors
Affiliations
Self-renewing stem cell populations are increasingly considered as resources for cell therapy and tools for drug discovery. Human pluripotent stem (hPS) cells in particular offer a virtually unlimited reservoir of homogeneous cells and can be differentiated toward diverse lineages. Many diseases show impairment in self-renewal or differentiation, abnormal lineage choice or other aberrant cell behavior in response to chemical or physical cues. To investigate these responses, there is a growing interest in the development of specific assays using hPS cells, artificial microenvironments and high content analysis. Several hurdles need to be overcome that can be grouped into three areas: (i) availability of robust, homogeneous, and consistent cell populations as a starting point; (ii) appropriate understanding and use of chemical and physical microenvironments; (iii) development of assays that dissect the complexity of cell populations in tissues while mirroring specific aspects of their behavior. Here we review recent progress in the culture of hPS cells and we detail the importance of the environment surrounding the cells with a focus on synthetic material and suitable high content analysis approaches. The technologies described, if properly combined, have the potential to create a paradigm shift in the way diseases are modeled and drug discovery is performed.
Maintenance of hPSCs under Xeno-Free and Chemically Defined Culture Conditions.
Lim J, Kim H, Rhie B, Lee M, Choi M, Hong S Int J Stem Cells. 2019; 12(3):484-496.
PMID: 31658510 PMC: 6881038. DOI: 10.15283/ijsc19090.
Ricci D, Nava M, Zandrini T, Cerullo G, Raimondi M, Osellame R Materials (Basel). 2017; 10(1).
PMID: 28772424 PMC: 5344595. DOI: 10.3390/ma10010066.
Phenotypic Assessment and the Discovery of Topiramate.
Maryanoff B ACS Med Chem Lett. 2016; 7(7):662-5.
PMID: 27437073 PMC: 4948003. DOI: 10.1021/acsmedchemlett.6b00176.
A high-content platform to characterise human induced pluripotent stem cell lines.
Leha A, Moens N, Meleckyte R, Culley O, Gervasio M, Kerz M Methods. 2015; 96:85-96.
PMID: 26608109 PMC: 4773406. DOI: 10.1016/j.ymeth.2015.11.012.
Differentiation of Cardiomyocytes from Human Pluripotent Stem Cells Using Monolayer Culture.
Batalov I, Feinberg A Biomark Insights. 2015; 10(Suppl 1):71-6.
PMID: 26052225 PMC: 4447149. DOI: 10.4137/BMI.S20050.